MwanzoSRPT • NASDAQ
add
Sarepta Therapeutics Inc
$ 17.39
Baada ya Saa za Kazi:(0.23%)-0.040
$ 17.35
Imefungwa: 12 Sep, 20:00:00 GMT -4 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 17.91
Bei za siku
$ 17.23 - $ 18.21
Bei za mwaka
$ 10.42 - $ 138.69
Thamani ya kampuni katika soko
1.82B USD
Wastani wa hisa zilizouzwa
9.55M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 611.09M | 68.38% |
Matumizi ya uendeshaji wa biashara | 138.56M | -0.60% |
Mapato halisi | 196.89M | 2,947.86% |
Kiwango cha faida halisi | 32.22 | 1,710.11% |
Mapato kwa kila hisa | 2.02 | 359.09% |
EBITDA | 126.42M | 1,476.67% |
Asilimia ya kodi ya mapato | -28.15% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 800.14M | -45.21% |
Jumla ya mali | 3.68B | 7.46% |
Jumla ya dhima | 2.32B | -1.05% |
Jumla ya hisa | 1.36B | — |
hisa zilizosalia | 97.71M | — |
Uwiano wa bei na thamani | 1.29 | — |
Faida inayotokana na mali | 8.09% | — |
Faida inayotokana mtaji | 11.07% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 196.89M | 2,947.86% |
Pesa kutokana na shughuli | 261.34M | 1,649.01% |
Pesa kutokana na uwekezaji | 32.21M | 132.69% |
Pesa kutokana na ufadhili | -23.82M | -159.66% |
Mabadiliko halisi ya pesa taslimu | 269.73M | 717.69% |
Mtiririko huru wa pesa | 454.69M | 1,643.42% |
Kuhusu
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1980
Tovuti
Wafanyakazi
1,372
